STRO
Sutro Biopharma Inc
Price:  
2.45 
USD
Volume:  
1,235,514.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

STRO WACC - Weighted Average Cost of Capital

The WACC of Sutro Biopharma Inc (STRO) is 8.4%.

The Cost of Equity of Sutro Biopharma Inc (STRO) is 8.40%.
The Cost of Debt of Sutro Biopharma Inc (STRO) is 8.45%.

Range Selected
Cost of equity 7.00% - 9.80% 8.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 9.90% 8.45%
WACC 6.9% - 9.8% 8.4%
WACC

STRO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 9.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.00% 9.90%
After-tax WACC 6.9% 9.8%
Selected WACC 8.4%